Big Gain For RedHill Biopharma Ltd.
Mon, Oct 16, 2023 at 07:18 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) jumped higher at $0.43, a gain of 34.5%. On Mon, Oct 16, 2023, RDHL:NASDAQ touched a New 2-Week High of $0.43. The stock appeared on our News Catalysts scanner on Tue, Oct 03, 2023 at 09:04 AM in the 'BIOTECH' category. From Mon, Oct 02, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Oct 13, 2023 at $0.54 with a volume of 16M+.
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- Tempest Therapeutics Inc. (TPST:NASDAQ), 85.16%
- Mmtec, Inc. (MTC:NASDAQ), 64.43%
- Secoo Holding Limited (SECO:NASDAQ), 59.47%
- Momentus Inc. (MNTS:NASDAQ), 55.95%
- PCTEL, Inc. (PCTI:NASDAQ), 47.21%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 45.28%
- MingZhu Logistics Holdings Limited (YGMZ:NASDAQ), 38.36%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.53%
- Almacenes Exito S.A. American Depositary Share each representing eight (8) (EXTO:NYSE), 34.46%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 34.23%